Nifurtimox
Showing 1 - 25 of 26
Women Who Were Exposed to Drug Nifurtimox During Pregnancy to
Not yet recruiting
- Chagas Disease
- Nifurtimox (BAYA2502)
-
Multiple Locations, ArgentinaMany locations
Aug 2, 2022
Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)
Completed
- Neuroblastoma
- Medulloblastoma
- Nifurtimox
- +2 more
-
San Diego, California
- +14 more
Dec 28, 2022
Chagas Disease Trial in Argentina, Bolivia, Colombia (Nifurtimox (Lampit, BAYA2502), Placebo)
Completed
- Chagas Disease
- Nifurtimox (Lampit, BAYA2502)
- Placebo
-
La Plata, Buenos Aires, Argentina
- +24 more
Aug 25, 2021
Nifurtimox in Chagas Disease,Parasitic Illness Mostly
Completed
- Chagas' Disease
- Lampit (Nifurtimox, BAYA2502)
-
Multiple Locations, ArgentinaMany locations
Apr 6, 2021
Chagas' Disease Trial in Buenos Aires (Nifurtimox (Lampit, BAYA2502))
Completed
- Chagas' Disease
- Nifurtimox (Lampit, BAYA2502)
-
Buenos Aires, Ciudad Auton. De Buenos Aires, ArgentinaFP Clinical Pharma
Dec 29, 2020
Bioequivalence Trial in Buenos Aires (Nifurtimox (Lampit, BAYA2502)_Test, Nifurtimox (Lampit, BAYA2502)_Reference)
Completed
- Bioequivalence
- Nifurtimox (Lampit, BAYA2502)_Test
- Nifurtimox (Lampit, BAYA2502)_Reference
-
Buenos Aires, Ciudad Auton. De Buenos Aires, ArgentinaFP Clinical Pharma
Jun 9, 2020
Trypanosoma Cruzi Infection, Chagas Disease Trial in Cochabamba, Tarija, Sucre (Benznidazole, Nifurtimox)
Active, not recruiting
- Trypanosoma Cruzi Infection
- Chagas Disease
- Benznidazole
- Nifurtimox
-
Cochabamba, Cercado, Bolivia
- +2 more
Jul 15, 2021
Tolerance for Chagas Disease Treatment
Unknown status
- Chagas Disease
- Clinical Manifestations
- +3 more
-
Buenos Aires, ArgentinaParasitology and Chagas Service, Buenos Aires Children´s Hospita
Apr 29, 2020
Chagas Disease Trial in Buenos Aires (Nifurtimox (Lampit, BAYA2502))
Completed
- Chagas Disease
- Nifurtimox (Lampit, BAYA2502)
-
Buenos Aires, Ciudad Auton. De Buenos Aires, ArgentinaFP Clinical Pharma
Dec 11, 2019
Chronic Chagas Disease Trial in Chile (40 mg Atorvastatin/day for 120 days P.O., Atorvastatin 80, Placebo)
Recruiting
- Chronic Chagas Disease
- 40 mg Atorvastatin/day for 120 days P.O.
- +2 more
-
Quinta Normal, Región Metropolitana, Chile
- +3 more
Nov 15, 2021
Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection, Sleeping Sickness Trial in Congo, The Democratic Republic of
Recruiting
- Trypanosomiasis, African
- +2 more
- Acoziborole
- Placebo
-
Mbuji-Mayi, Kasai-Oriental, Congo, The Democratic Republic of the
- +3 more
Feb 15, 2022
Congenital Chagas Disease: Long Term Follow up of Treated
Completed
- Chagas Disease
- Chagas Cardiomyopathy
-
Buenos Aires, ArgentinaParasitology Division, Children's Hospital "R Gutierrez" of Buen
Apr 23, 2020
Chagas Disease Trial in Buenos Aires, Corrientes, Santiago Del Estero (Short regimen of benznidazole, Standard treatment with
Recruiting
- Chagas Disease
- Short regimen of benznidazole
- Standard treatment with benznidazole
-
Buenos Aires, Argentina
- +5 more
Sep 16, 2021
Chagas' Disease (Chronic) Nos Trial in Barcelona (Fexinidazole, Placebo Oral Tablet)
Completed
- Chagas' Disease (Chronic) Nos
- Fexinidazole
- Placebo Oral Tablet
-
Barcelona, Catalunia, SpainHospital Clinic
Sep 21, 2020
Human African Trypanosomiasis (HAT), Sleeping Sickness Trial in Central African Republic, Congo, Congo, The Democratic Republic
Completed
- Human African Trypanosomiasis (HAT)
- Sleeping Sickness
- Fexinidazole
- +2 more
-
Batangafo, Central African Republic
- +9 more
Feb 17, 2018
Chagas Disease Trial in Bucaramanga (Nifurtimox, Benznidazole, Placebo)
Unknown status
- Chagas Disease
- Nifurtimox
- +2 more
-
Bucaramanga, Santander, ColombiaFundación Oftalmológica de Santander - Clínica Ardila Lulle (FOS
Jul 18, 2017
Chagas Disease Trial in Buenos Aires (Nifurtimox (BAYa2502))
Completed
- Chagas Disease
- Nifurtimox (BAYa2502)
-
Buenos Aires, Ciudad Auton. de Buenos Aires, Argentina(unnamed)
Nov 11, 2016
Trypanosomiasis, African Trial in Congo, Congo, The Democratic Republic of the (Eflornithine, Nifurtimox)
Completed
- Trypanosomiasis, African
- Eflornithine
- Nifurtimox
-
Isangi, Congo, The Democratic Republic of the
- +3 more
Sep 28, 2016
Chagas Disease Trial in Buenos Aires (Nifurtimox (BAYa2502) (4 x 30 mg tablet), Nifurtimox (BAYa2502) (slurry of 4 x 30 mg
Completed
- Chagas Disease
- Nifurtimox (BAYa2502) (4 x 30 mg tablet)
- +2 more
-
Buenos Aires, Ciudad Auton. de Buenos Aires, Argentina(unnamed)
Oct 14, 2015
Nifurtimox Transfer Into Breastmilk In Lactating Chagas Disease
Completed
- Chagas Disease
- Lactation
-
Buenos Aires, ArgentinaParasitology and Chagas Service, Buenos Aires Children´s Hospita
Mar 17, 2015
Human African Trypanosomiasis Trial in Congo (Nifurtimox-Eflronithine Combination Treatment (NECT))
Completed
- Human African Trypanosomiasis
- Nifurtimox-Eflronithine Combination Treatment (NECT)
-
Kwamouth, Bandundu, Congo
- +5 more
May 30, 2013
Chronic Chagas Disease, Indeterminate Trial in Cochabamba, Tarija (E1224, Benznidazole, Placebo)
Unknown status
- Chronic Chagas Disease, Indeterminate
- E1224
- +2 more
-
Cochabamba, Bolivia
- +1 more
Dec 19, 2011
Neuroblastoma Trial in St. Louis, Burlington (Nifurtimox)
Completed
- Neuroblastoma
- Nifurtimox
-
St. Louis, Missouri
- +1 more
Oct 22, 2009